Carlyle Group’s 1Life Healthcare ONEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,612,681
| Closed | -$227M | – | 32 |
|
|
2022
Q4 | $227M | Hold |
13,612,681
| – | – | 6.62% | 4 |
|
|
2022
Q3 | $233M | Hold |
13,612,681
| – | – | 7.41% | 4 |
|
|
2022
Q2 | $107M | Hold |
13,612,681
| – | – | 1.84% | 5 |
|
|
2022
Q1 | $151M | Hold |
13,612,681
| – | – | 1.8% | 4 |
|
|
2021
Q4 | $239M | Hold |
13,612,681
| – | – | 2.49% | 4 |
|
|
2021
Q3 | $276M | Hold |
13,612,681
| – | – | 2.18% | 5 |
|
|
2021
Q2 | $450M | Hold |
13,612,681
| – | – | 3.05% | 5 |
|
|
2021
Q1 | $532M | Hold |
13,612,681
| – | – | 4.03% | 5 |
|
|
2020
Q4 | $594M | Sell |
13,612,681
-7,000,000
| -34% | -$239M | 7.96% | 3 |
|
|
2020
Q3 | $585M | Hold |
20,612,681
| – | – | 7.96% | 3 |
|
|
2020
Q2 | $749M | Sell |
20,612,681
-7,545,000
| -27% | -$213M | 8.48% | 3 |
|
|
2020
Q1 | $511M | Buy |
+28,157,681
| New | +$617M | 21.66% | 2 |
|
Carlyle Group's ONEM Position: Q1 2023 in Review
Carlyle Group sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 13,612,681 shares — an estimated $227M sold.
Carlyle Group first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $749M in Q2 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.
- Carlyle Group reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
- Carlyle Group sold 13,612,681 1Life Healthcare shares in Q1 2023, an estimated $227M.
- Carlyle Group first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
- Carlyle Group's 1Life Healthcare position peaked at $749M in Q2 2020.
- 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.
Based on Carlyle Group's 13F filing for Q1 2023, filed 5 May 2023.